Quebec SEAO #202603IN-265

Héma-Québec Market Survey for Next-Generation Sequencer (NGS) for HLA Typing

Héma-Québec, a Montréal-based medical organization, is conducting a market evaluation for next-generation sequencer (NGS) equipment for high-resolution HLA typing in its laboratory. - Government Buyer: - Héma-Québec (Montréal, Quebec, Canada) - Products/Services Requested: - Next-generation sequencer (NGS) for high-resolution HLA typing - Medical laboratory equipment and accessories - No specific part numbers or quantities provided - OEMs and Vendors: - No OEMs or vendors are named in the notice - Unique/Notable Requirements: - Equipment must be suitable for high-resolution HLA typing using NGS technology - The request is part of a technological watch to anticipate future laboratory needs - No commitment to purchase; this is an information-gathering exercise - Additional Details: - Published on SEAO under 'Avis d'intérêt 202603IN-265 - Séquenceur' - No service or maintenance requirements specified

Description

HÉMA-QUÉBEC is seeking to evaluate market equipment for high-resolution HLA typing using a next-generation sequencer (NGS) as part of its activities. This initiative is part of a technological watch and anticipation of future laboratory needs. The procurement involves the supply of goods related to medical equipment and accessories. The deadline for submission is July 15, 2026, and the location is Montréal, Quebec, Canada.

View original listing